Walgreens Boots Alliance has reported its financial performance for the first quarter of fiscal 2025, ending November 30, 2024. The company showed a significant sales increase of 7.5%.
7.5% Sales Increase
The company achieved sales of $39.5 billion, a 7.5% increase compared to the prior year. The U.S. Healthcare and International segments were key contributors to this growth.
Key Growth Drivers
Despite a decrease in U.S. retail sales, the company managed to increase its revenue through healthcare services and international operations. Sales in the U.S. Healthcare segment reached $2.2 billion. The International segment showed a strong performance with a 10.2% increase in sales to $6.4 billion, supported by favorable currency impacts and growth in Germany and the UK.
Future Outlook
The company maintains its fiscal 2025 adjusted EPS guidance of $1.40 to $1.80. Plans include strengthening the healthcare segment and optimizing the retail network to control costs. CEO Tim Wentworth emphasized the importance of a pharmacy-led operating model.
In summary, Walgreens Boots Alliance delivered impressive first-quarter results, providing confidence in the company's sustainable performance going forward. The growth in healthcare and international sectors is expected to offset challenges in the US retail market.
